Dr. Jorge Enrique Balandrin M.D.

Recommended Articles

• What Are the Types of Bipolar Disorder?

  What is bipolar disorder?Bipolar disorder is a mental illness characterized by extreme mood swings. The mood swings can be extremely high or low. They can last a few hours, days, weeks or even months. The mood swings consist of mixed emotions both of extreme happiness or extreme depression.Bipolar...

• 319 Pill

  319 PillThis pill is round in shape and white in color, and has an imprint of number “319”. It has been identified as tramadol hydrochloride 50 mg. It is used to treat restless legs syndrome (RLS), back pain, chronic pain, and fibromyalgia. It is supplied by Zydus Pharmaceuticals and belongs to...

• Can Snacking Help Promote Weight Loss?

  You may find yourself wondering how to maintain a healthy and slim physique without eliminating snacks. In the past, diet programs often eliminated snacking as the first and fastest way to reduce calories. Today, common knowledge is that snacks don't prevent weight loss if smart choices are made. In...

• The Human Heart: Function, Chambers, and Location

  IntroductionThe human heart is a part of the cardiovascular system that is situated in the middle of the chest between the lungs. Its exact location is slightly positioned to the left and behind the sternum (breastbone). The size of the heart is approximately the size of your fist. Its function...

• Walk Your Way to a Healthy Life

  Walking is one of the simplest forms of exercise and does not require any equipment, other than a pair of good shoes.Julia Valentour, MS, exercise physiologist and program coordinator for the American Council on Exercise, suggests that exercise doesn't have to be hard to be very effective. If a...

• Sleep Positioners May Increase a Baby's Risk of Death

  A warning has been issued by the FDA and the Consumer Product Safety Commission (CPSC) against the use of sleep-positioning devices for babies. About 12 deaths have been reported with the use of these devices in the last 13 years.FDA principal deputy commissioner, Joshua Sharfstein, reported that...